Results 191 to 200 of about 158,698 (267)

Household wealth and childhood anaemia in resource-constrained settings: a Bayesian multilevel analysis. [PDF]

BMC Public Health
Acquah FN.
europepmc   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, Dyfrig A. Hughes, Katherine Payne, Maria Tsakiroglou, Paul Ross, Rena Chauhan, Simon Jenkinson, Jessica Keen, Sophie Harding, Eleanor Lau, Michael Braun, Roshan Agarwal, Richard Adams, Elisabeth Rolf, Farah Al‐Sheikhli, Sarah Mitchell, Ruth Hammond, Rosie Roberts, Lorna Cairns, Shirley Heggarty, Janet Graham, Justin Mencel, Munir Pirmohamed   +24 more
wiley   +1 more source

Breastfeeding and complementary feeding practices in Madagascar: results of a secondary analysis of the freeBily trial. [PDF]

Int Breastfeed J
Marchese V, Brito A, Rakotozandrindrainy R, Schwarz NG, Rakotozandrindrainy N, Rasamoelina T, Andrianarivelo MR, Solonirina J, Ratiaharison EF, Radomanana M, Randrianarisoa T, Klein P, Hameister J, Gunga L, Kislaya I, Jaeger A, Dam GV, May J, Rakotoarivelo RA, Fusco D, freeBILy consortium.   +20 more
europepmc   +1 more source

Pharmacometric evaluation of pre‐referral rectal artesunate in children with severe malaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Parenteral artesunate is the preferred first‐line treatment for severe malaria. Pre‐referral rectal artesunate suppositories are recommended where parenteral treatment is inaccessible. In this study, we compared dihydroartemisinin exposure and model‐predicted early parasite clearance following rectal artesunate and intravenous artesunate in ...
Ayorinde Adehin, Marie A. Onyamboko, Caterina Fanello, Nicholas J. White, Nicholas P. J. Day, Richard M. Hoglund, Joel Tarning   +6 more
wiley   +1 more source

Implications of changes in WHO haemoglobin elevation adjustment guidelines on global, regional, and national anaemia burden, 1990-2023: a population-based modelling study. [PDF]

Lancet Haematol
Teply CJ, Gardner WM, Noyes TS, McHugh TA, Tandiono HA, Gusti Ayu Nanditha N, Harris AA, Perumal N, Markt-Maloney J, Howatt BC, Taylor HJ, Humphrey K, Bhutta ZA, Girelli D, Hay SI, Murray CJL, Musallam KM, Nnodu O, Suchdev PS, Kassebaum NJ.   +19 more
europepmc   +1 more source

Megaloblastic Anaemia

Journal of the Royal College of Physicians of Edinburgh, 2020
openaire   +2 more sources

The impact of medication shortages on paediatric care: A retrospective impact analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Medication shortages are a growing global concern, with potentially greater consequences in paediatric patients because of the limited availability of safe, evidence‐based and appropriately formulated medication. This study aimed to evaluate the impact of medication shortages on paediatric patients by assessing the suitability and safety of ...
Maaike Johanna Rutten ‐ van Kranenburg, Laurens Christiaan van Rijn, Elisabeth Johanna Ruijgrok, Sinno Henricus Paulus Simons, Brigitta Carolina Maria Witjes, Jan‐Dietert Christoffer Brugma, Robert Bernard Flint   +6 more
wiley   +1 more source

Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts. [PDF]

Eur J Clin Invest
Rigutini AG, Bucci T, Askarinejad A, Tartaglia E, Rossi M, Becattini C, Boriani G, Tse HF, Chao TF, Lip GYH.   +9 more
europepmc   +1 more source

Nutritional Anaemias

International Journal of Clinical Practice, 1968
openaire   +2 more sources

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

British Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir   +5 more
wiley   +1 more source